BENDL, Jaroslav, Miloš MUSIL, Jan ŠTOURAČ, Jaroslav ZENDULKA, Jiří DAMBORSKÝ a Jan BREZOVSKÝ. PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions. PLOS COMPUTATIONAL BIOLOGY 12: e100496. 2016, roč. 12, č. 5, s. "nestrankovano", 18 s. ISSN 1553-734X. Dostupné z: https://dx.doi.org/10.1371/journal.pcbi.1004962.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions
Autoři BENDL, Jaroslav (203 Česká republika, domácí), Miloš MUSIL (203 Česká republika, domácí), Jan ŠTOURAČ (203 Česká republika, domácí), Jaroslav ZENDULKA (203 Česká republika), Jiří DAMBORSKÝ (203 Česká republika, garant, domácí) a Jan BREZOVSKÝ (203 Česká republika, domácí).
Vydání PLOS COMPUTATIONAL BIOLOGY 12: e100496, 2016, 1553-734X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10600 1.6 Biological sciences
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.542
Kód RIV RIV/00216224:14310/16:00092839
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1371/journal.pcbi.1004962
UT WoS 000379348100043
Klíčová slova anglicky GENETIC-VARIATION; REGULATORY VARIANTS; SEQUENCE VARIATION; PROTEIN FUNCTION; CAUSAL VARIANTS; COMPLEX TRAITS; MUTATIONS; DISEASE; CANCER; ELEMENTS
Štítky AKR, rivok
Změnil Změnila: Ing. Andrea Mikešková, učo 137293. Změněno: 9. 4. 2017 15:35.
Anotace
An important message taken from human genome sequencing projects is that the human population exhibits approximately 99.9% genetic similarity. Variations in the remaining parts of the genome determine our identity, trace our history and reveal our heritage. The precise delineation of phenotypically causal variants plays a key role in providing accurate personalized diagnosis, prognosis, and treatment of inherited diseases. Several computational methods for achieving such delineation have been reported recently. However, their ability to pinpoint potentially deleterious variants is limited by the fact that their mechanisms of prediction do not account for the existence of different categories of variants. Consequently, their output is biased towards the variant categories that are most strongly represented in the variant databases. Moreover, most such methods provide numeric scores but not binary predictions of the deleteriousness of variants or confidence scores that would be more easily understood by users. We have constructed three datasets covering different types of disease-related variants, which were divided across five categories: (i) regulatory, (ii) splicing, (iii) missense, (iv) synonymous, and (v) nonsense variants. These datasets were used to develop category-optimal decision thresholds and to evaluate six tools for variant prioritization: CADD, DANN, FATHMM, FitCons, FunSeq2 and GWAVA. This evaluation revealed some important advantages of the category-based approach. The results obtained with the five best-performing tools were then combined into a consensus score. Additional comparative analyses showed that in the case of missense variations, protein-based predictors perform better than DNA sequence-based predictors.The web server is freely available to the community at http://loschmidt.chemi.muni.cz/predictsnp2.
Návaznosti
LO1214, projekt VaVNázev: Centrum pro výzkum toxických látek v prostředí (Akronym: RECETOX)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Centrum pro výzkum toxických látek v prostředí
676559, interní kód MUNázev: ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences (Akronym: ELIXIR-EXCELERATE)
Investor: Evropská unie, ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences, RI Research Infrastructures (Excellent Science)
VytisknoutZobrazeno: 26. 4. 2024 19:33